浓缩血小板制品在创面修复中应用的全国专家共识(2020版)

2020-11-30 中国老年医学学会烧创伤分会 中华烧伤杂志.2020,36(11):993-1002.

以浓缩血小板衍生物为代表的创面生物治疗收到人们的关注,但由于在制备的质量控制、使用方式等方面不统一,导致有一些不一致观点。本共识编写组成人通过复习大量文献,筛选出高质量的证据文章,结核创面修复领域专家

中文标题:

浓缩血小板制品在创面修复中应用的全国专家共识(2020版)

发布日期:

2020-11-30

简要介绍:

以浓缩血小板衍生物为代表的创面生物治疗收到人们的关注,但由于在制备的质量控制、使用方式等方面不统一,导致有一些不一致观点。本共识编写组成人通过复习大量文献,筛选出高质量的证据文章,结核创面修复领域专家反复的研讨,形成具有指导意义的专家共识,以指导从事创面修复的医护人员学习、规范地使用浓缩血小板治疗技术。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2166120, encodeId=836221661200c, content=<a href='/topic/show?id=fc5310e330cd' target=_blank style='color:#2F92EE;'>#浓缩血小板#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=107330, encryptionId=fc5310e330cd, topicName=浓缩血小板)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=litao2022, createdTime=Wed Nov 01 15:08:56 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1221863, encodeId=fd35122186382, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:10:01 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221862, encodeId=ddad12218622c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:09:36 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198936, encodeId=67b5119893632, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Thu Mar 03 08:34:13 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057795, encodeId=3319105e79510, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:26:46 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2023-11-01 litao2022 来自上海
  2. [GetPortalCommentsPageByObjectIdResponse(id=2166120, encodeId=836221661200c, content=<a href='/topic/show?id=fc5310e330cd' target=_blank style='color:#2F92EE;'>#浓缩血小板#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=107330, encryptionId=fc5310e330cd, topicName=浓缩血小板)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=litao2022, createdTime=Wed Nov 01 15:08:56 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1221863, encodeId=fd35122186382, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:10:01 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221862, encodeId=ddad12218622c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:09:36 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198936, encodeId=67b5119893632, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Thu Mar 03 08:34:13 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057795, encodeId=3319105e79510, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:26:46 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2022-05-23 ms3000001192921135

    👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2166120, encodeId=836221661200c, content=<a href='/topic/show?id=fc5310e330cd' target=_blank style='color:#2F92EE;'>#浓缩血小板#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=107330, encryptionId=fc5310e330cd, topicName=浓缩血小板)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=litao2022, createdTime=Wed Nov 01 15:08:56 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1221863, encodeId=fd35122186382, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:10:01 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221862, encodeId=ddad12218622c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:09:36 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198936, encodeId=67b5119893632, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Thu Mar 03 08:34:13 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057795, encodeId=3319105e79510, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:26:46 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2022-05-23 ms3000001192921135

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2166120, encodeId=836221661200c, content=<a href='/topic/show?id=fc5310e330cd' target=_blank style='color:#2F92EE;'>#浓缩血小板#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=107330, encryptionId=fc5310e330cd, topicName=浓缩血小板)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=litao2022, createdTime=Wed Nov 01 15:08:56 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1221863, encodeId=fd35122186382, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:10:01 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221862, encodeId=ddad12218622c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:09:36 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198936, encodeId=67b5119893632, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Thu Mar 03 08:34:13 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057795, encodeId=3319105e79510, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:26:46 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2022-03-03 1937600869

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2166120, encodeId=836221661200c, content=<a href='/topic/show?id=fc5310e330cd' target=_blank style='color:#2F92EE;'>#浓缩血小板#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=107330, encryptionId=fc5310e330cd, topicName=浓缩血小板)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=litao2022, createdTime=Wed Nov 01 15:08:56 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1221863, encodeId=fd35122186382, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:10:01 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221862, encodeId=ddad12218622c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf836411226, createdName=ms3000001192921135, createdTime=Mon May 23 23:09:36 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198936, encodeId=67b5119893632, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Thu Mar 03 08:34:13 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057795, encodeId=3319105e79510, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:26:46 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-05 H8888888

    受益匪浅

    0

拓展阅读

创面修复科病史采集全国专家共识(2021年版)

中华医学会烧伤外科学分会 · 2021-12-01

脱细胞基质软组织创面修复材料产品注册审查指导原则(征求意见稿)

国家药品监督管理局医疗器械技术审评中心 · 2024-04-11